Neurogenic Bladder Treatment Electrical Stimulation Tactile Assessment Method, System and Wearable Device

Abstract

The present invention discloses a method, system and wearable device for electrostimulation tactile evaluation in the treatment of neurogenic bladder. The system relates to the technical field of non-invasive neuromodulation treatment and electrostimulation tactile evaluation of neurogenic bladder. It includes collecting and analyzing the treatment data of neurogenic bladder, and comprehensively analyzing and optimizing and adjusting. By applying the electrical pulses output by the stimulator unit to a specific nerve electrode and capturing and decoding the characteristics of the plantar movement signal, the present invention collects and analyzes the treatment data of neurogenic bladder, adaptively adjusts the position of the nerve electrode and the stimulation parameters, and realizes the non-invasive treatment of neurogenic bladder, solving the problems of the deficiencies of the existing treatment technologies.

Description

Technical Field

[0001] The present invention relates to the technical field of electrical stimulation tactile evaluation, and particularly to a method, a system and a wearable device for electrical stimulation tactile evaluation in the treatment of neurogenic bladder. Background Art

[0002] Neurogenic bladder usually has different clinical manifestations according to the degree and location of nerve lesions. For example, spinal cord injuries at different segments and degrees can lead to different types of lower urinary tract dysfunction. 42% of patients with spinal cord central injury syndrome are accompanied by neurogenic bladder. In patients with non-traumatic spinal cord injury, detrusor overactivity and detrusor-sphincter dyssynergia are the main causes of severe upper urinary tract damage. Approximately 77.6% of patients with hereditary spastic paraplegia and 61% of patients with caudal regression syndrome will develop neurogenic bladder. The lower urinary tract symptoms of neurogenic bladder include poor prognosis of storage, micturition, and post-micturition symptoms. Storage symptoms include urgency, frequency, nocturia, urinary incontinence, enuresis, etc.; micturition symptoms include difficulty in urination, incomplete bladder emptying, urinary retention, dysuria, etc.; it can cause a variety of long-term complications, and the most serious ones are upper urinary tract damage and renal failure. Currently, the treatment methods include assisted micturition methods such as Valsalva micturition, with unstable effects; oral drug treatment, including drugs for treating detrusor overactivity and drugs for reducing urine production, with limited efficacy and side effects; surgical operations mainly include surgical procedures for reconstructing storage function such as bladder augmentation, and surgical procedures for reconstructing micturition function such as detrusor plasty and sacral nerve implantation. The surgical trauma risk is high and the cost is expensive. Currently, there is no non-invasive application plan for the treatment and evaluation of neurogenic bladder.

[0003] The existing electrical stimulation tactile evaluation method for bladder treatment uses a wearable ultrasonic bladder volume monitor for continuous monitoring of bladder volume; an integrated flexible ultrasonic device for continuous monitoring of bladder volume, which combines a flexible, inflatable ultrasonic transducer and miniaturized control electronics and has wireless data transmission capabilities.

[0004] For example, the wearable device and tactile feedback method, device, and storage medium disclosed in the patent publication No. CN111399645B include: a touchpad, touch electrodes, a controller, and an adjustment module; wherein, the touchpad is used to detect a touch operation and generate a touch signal according to the touch operation; the controller is connected to the touchpad, used to receive the touch signal, obtain tactile parameters according to the touch signal, and output a control signal according to the tactile parameters; the adjustment module is respectively connected to the controller and the tactile electrodes, used to generate an electrical stimulation signal matching the tactile parameters according to the control signal, and output the electrical stimulation signal through the tactile electrodes.

[0005] For example, the electro - tactile feedback wearable system for kinesthetic - tactile hybrid rendering disclosed in the patent application with the publication number of CN117666778A includes: a host computer, a stimulation output module, a tactile feedback glove, and a VR external device; the host computer is used to provide a virtual reality scene, interact with digital content according to the VR external device, and generate tactile information; the tactile feedback glove includes a glove body, a fingertip tactile electrode array and a finger kinesthetic electrode array arranged on the glove body; the stimulation output module is connected to the tactile feedback glove, and outputs a stimulation current to the tactile feedback glove according to the tactile information to activate some or all of the stimulation electrodes, so as to stimulate the fingers to generate kinesthetic feedback and achieve kinesthetic - tactile hybrid rendering.

[0006] However, in the process of implementing the technical solution of the present invention in the embodiments of the present application, it is found that the above - mentioned technology has at least the following technical problems:

[0007] When this system is applied to the application scenario of non - invasive extracorporeal treatment of neurogenic bladder, it lacks target coverage of the thoracic segment, lumbar segment, lumbosacral segment of the spinal nerves and the iliac wing. Due to the complexity of neurogenic bladder diseases, the target coverage of nerve electrodes is very important. When the patient moves, the electrodes move, and the relative position between the electrodes and the skin changes, which affects the accuracy of nerve stimulation and the stability of signals. As a result, the treatment effect is unstable. During the process of signal transmission from the stimulator unit to the nerve electrode unit, there will be transmission delay. When multiple channels work simultaneously, the signal frequency characteristics between electronic components cause pulse waveform distortion or mutual influence between channels, affecting synchronization, and there is a problem of insufficient accuracy in the electro - tactile evaluation of bladder treatment. Summary of the Invention

[0008] The embodiments of the present application provide a method, a system and a wearable device for electro - tactile evaluation of neurogenic bladder treatment, solve the problem of insufficient accuracy of wearable devices for neurogenic bladder treatment in the prior art, and improve the accuracy of wearable devices for neurogenic bladder treatment.

[0009] The embodiments of the present application provide an electrostimulation tactile wearable device for the treatment of neurogenic bladder, including the following steps: a stimulator unit, a nerve electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is required and the stimulation parameters. The stimulation strategy unit formulates a stimulation plan according to the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electrical pulses according to the received stimulation plan and sends the electrical pulses to the nerve electrode unit through wires or wirelessly. The nerve electrode unit covers the thoracic vertebrae, lumbar vertebrae, sacrum, and iliac wings, and transmits the electrical pulses to the patient's nervous system to complete the stimulation process. Among them, the stimulator unit is the part that provides synchronous output and asynchronous output of multi-channel stimulation pulses. The multiple electrical pulses output by the stimulator are independently controllable. The amplitude parameter, pulse width parameter, and stimulation frequency parameter of the multi-channel electrical pulses are independently adjustable. During stimulation, target screening and related motion capture are completed through the first-layer electrode sites and the second-layer electrode sites.

[0010] Further, the electrostimulation tactile evaluation method of the electrostimulation tactile wearable device for the treatment of neurogenic bladder is characterized by including the following steps: collecting and processing neurogenic bladder treatment data through the nerve electrode unit and the motion capture unit in the electrostimulation tactile wearable device for the treatment of neurogenic bladder; analyzing the neurogenic bladder treatment data through the signal decoding unit in the electrostimulation tactile wearable device for the treatment of neurogenic bladder to obtain a neurogenic bladder treatment signal quality evaluation value and a neurogenic bladder treatment signal synchronization evaluation value; comprehensively analyzing through the signal decoding unit in the electrostimulation tactile wearable device for the treatment of neurogenic bladder to obtain a neurogenic bladder treatment signal accuracy evaluation value; comparing and analyzing the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the electrostimulation tactile wearable device for the treatment of neurogenic bladder to optimize and adjust the neurogenic bladder treatment signal quality method; comparing and analyzing the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value to optimize and adjust the neurogenic bladder treatment signal synchronization method; comparing and analyzing the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value to optimize and adjust the neurogenic bladder treatment signal accuracy method.

[0011] Further, the specific steps for collecting and processing neurogenic bladder treatment data are as follows: Collect the original neurogenic bladder treatment data by contacting the sole, toes, instep, dorsal surface of the foot, etc. with the neurogenic bladder treatment electrical stimulation tactile wearable device; Clean and denoise the original neurogenic bladder treatment data to obtain the neurogenic bladder treatment data, where the neurogenic bladder treatment data includes neurogenic bladder treatment signal quality data and neurogenic bladder treatment signal synchronization data.

[0012] Further, the specific process for obtaining the neurogenic bladder treatment signal synchronization evaluation value is as follows: Obtain the movement amplitude and angle characteristics of the preset neurogenic bladder treatment signal synchronization time detection points through the sensing devices at the sole, toes, instep, and dorsal surface of the foot; Obtain the signal frequency characteristics of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; Obtain the signal transmission delay of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; Obtain the signal drift rate of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; Obtain the signal maximum phase of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; Obtain the signal minimum phase of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; Obtain the time stamp of the preset neurogenic bladder treatment signal synchronization time detection points through the signal decoding unit; The neurogenic bladder treatment signal synchronization data includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase, and time stamp; Analyze the neurogenic bladder treatment signal synchronization data to obtain the neurogenic bladder treatment signal synchronization evaluation value.

[0013] Further, the specific steps for comprehensively analyzing and obtaining the neurogenic bladder treatment signal accuracy evaluation value are as follows: Obtain the signal transmission rate of the preset neurogenic bladder treatment signal accuracy time detection points through the signal decoding unit; Comprehensively analyze the neurogenic bladder treatment signal synchronization evaluation value, signal transmission rate, and neurogenic bladder treatment signal quality evaluation value to obtain the neurogenic bladder treatment signal accuracy evaluation value.

[0014] Further, the specific steps for optimizing and adjusting the neurogenic bladder treatment signal quality method are as follows: If the neurogenic bladder treatment signal quality evaluation value is lower than or equal to the first threshold of the neurogenic bladder treatment signal quality evaluation value, there is no need to optimize and adjust the neurogenic bladder treatment signal quality method; If the neurogenic bladder treatment signal quality evaluation value is higher than the first threshold of the neurogenic bladder treatment signal quality evaluation value, match the corresponding adjustment plan in the neurogenic bladder treatment database according to the difference between the neurogenic bladder treatment signal quality evaluation value and the first threshold of the neurogenic bladder treatment signal quality evaluation value.

[0015] Further, the specific steps of the method for optimizing and adjusting the synchronization of neurogenic bladder treatment signals are as follows: If the evaluation value of the synchronization of neurogenic bladder treatment signals is greater than or equal to the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals, there is no need to optimize and adjust the method for the synchronization of neurogenic bladder treatment signals; if the evaluation value of the synchronization of neurogenic bladder treatment signals is lower than the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the evaluation value of the synchronization of neurogenic bladder treatment signals and the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals.

[0016] Further, the specific steps of the method for optimizing and adjusting the accuracy of neurogenic bladder treatment signals are as follows: Extract the comprehensive threshold of the evaluation value of the accuracy of neurogenic bladder treatment signals from the neurogenic bladder treatment database, and compare the evaluation value of the accuracy of neurogenic bladder treatment signals with the comprehensive threshold of the evaluation value of the accuracy of neurogenic bladder treatment signals; if the evaluation value of the accuracy of neurogenic bladder treatment signals is greater than or equal to the comprehensive threshold of the evaluation value of the accuracy of neurogenic bladder treatment signals, there is no need to optimize and adjust the method for the accuracy of neurogenic bladder treatment signals; if the evaluation value of the accuracy of neurogenic bladder treatment signals is lower than the comprehensive threshold of the evaluation value of the accuracy of neurogenic bladder treatment signals, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the evaluation value of the accuracy of neurogenic bladder treatment signals and the comprehensive threshold of the evaluation value of the accuracy of neurogenic bladder treatment signals.

[0017] The embodiment of the present application provides a neurogenic bladder treatment electrical stimulation tactile evaluation system, including: a module for collecting neurogenic bladder treatment data, a module for analyzing neurogenic bladder treatment data, a comprehensive analysis module, and an optimization and adjustment module. The module for collecting neurogenic bladder treatment data is used to collect and process neurogenic bladder treatment data through the nerve electrode unit and the motion capture unit in the neurogenic bladder treatment electrical stimulation tactile wearable device. The module for analyzing neurogenic bladder treatment data is used to analyze the neurogenic bladder treatment data through the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain the evaluation value of the quality of the neurogenic bladder treatment signal and the evaluation value of the synchronization of the neurogenic bladder treatment signal. The comprehensive analysis module is used to comprehensively analyze through the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain the evaluation value of the accuracy of the neurogenic bladder treatment signal. The optimization and adjustment module is used to compare and analyze the evaluation value of the quality of the neurogenic bladder treatment signal with the first threshold of the evaluation value of the quality of the neurogenic bladder treatment signal through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize and adjust the method for the quality of the neurogenic bladder treatment signal; compare and analyze the evaluation value of the synchronization of the neurogenic bladder treatment signal with the second threshold of the evaluation value of the synchronization of the neurogenic bladder treatment signal, and optimize and adjust the method for the synchronization of the neurogenic bladder treatment signal; compare and analyze the evaluation value of the accuracy of the neurogenic bladder treatment signal with the comprehensive threshold of the evaluation value of the accuracy of the neurogenic bladder treatment signal, and optimize and adjust the method for the accuracy of the neurogenic bladder treatment signal.

[0018] One or more technical solutions provided in the embodiment of the present application have at least the following technical effects or advantages:

[0019] 1. Solved the technical problem of non-invasive treatment of neurogenic bladder in vitro. Adopted an extracorporeal wearable non-invasive treatment plan to achieve non-contact and non-invasive treatment of the nerves related to bladder function regulation, which is convenient for application.

[0020] 2. By collecting and analyzing neurogenic bladder treatment data, obtaining the evaluation value of the quality of the neurogenic bladder treatment signal and the evaluation value of the synchronization of the neurogenic bladder treatment signal, comprehensively analyzing and optimizing and adjusting, thereby improving the accuracy of the wearable application of neurogenic bladder electrical stimulation treatment and solving the problems of the prior art.

[0021] 3. By collecting and analyzing neurogenic bladder treatment data, obtaining the evaluation value of the quality of the neurogenic bladder treatment signal and the evaluation value of the synchronization of the neurogenic bladder treatment signal, ensuring the effectiveness and reliability of the treatment signal, thereby improving the treatment effect. The device is simple and convenient to use, and is safer and has no side effects compared with traditional treatment methods.

[0022] 4. By comprehensively analyzing, obtain the accuracy evaluation value of the neurogenic bladder treatment signal and optimize and adjust it to improve the treatment effect, reduce the discomfort during the treatment process, and enhance the patient's treatment experience. Description of the Drawings

[0023] Figure 1 Schematic structural diagram of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0024] Figure 2 Schematic flow diagram of the electro-stimulating tactile evaluation method for neurogenic bladder treatment provided by an embodiment of the present application;

[0025] Figure 3 Schematic structural diagram of the electro-stimulating tactile evaluation system for neurogenic bladder treatment provided by an embodiment of the present application;

[0026] Figure 4 Rear view of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0027] Figure 5 Schematic diagram for finding the optimal electrode position and capturing actions of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0028] Figure 6 Schematic diagram for capturing actions of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0029] Figure 7 Schematic diagram for the stimulation strategy and action capture of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0030] Figure 8 Schematic diagram for the quick slope discrimination of the signal decoding unit of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0031] Figure 9 Schematic diagram for the 1 / 4 cycle integration method and quick slope discrimination of the signal decoding unit of the electro-stimulating tactile wearable device for neurogenic bladder treatment provided by an embodiment of the present application;

[0032] Figure 10 Rear view of the electro-stimulating tactile wearable device for neurogenic bladder treatment after being applied to the human body provided by an embodiment of the present application;

[0033] Figure 11 Side view of the electro-stimulating tactile wearable device for neurogenic bladder treatment after being applied to the human body provided by an embodiment of the present application. Detailed Embodiments

[0034] Embodiments of the present application provide a method, system, and wearable device for tactile evaluation of electrical stimulation for neurogenic bladder treatment, which solve the limitation in the prior art that there is no non-invasive extracorporeal treatment technology for neurogenic bladder, and solve the problem of insufficient accuracy in covering the nerve targets for electrical stimulation treatment of neurogenic bladder. By collecting and analyzing the neurogenic bladder treatment data, an evaluation value of the signal quality of the neurogenic bladder treatment and an evaluation value of the signal synchronization of the neurogenic bladder treatment are obtained, and through comprehensive analysis and optimization adjustment, the accuracy of the wearable application of the electrical stimulation treatment for neurogenic bladder is improved, thus solving the deficiencies in the prior art.

[0035] The technical solution in the embodiments of the present application aims to solve the problem of insufficient accuracy in the wearable treatment of neurogenic bladder as described above, and the general idea is as follows:

[0036] Through the multi-target nerve electrode coverage technology and the optimal round-robin strategy for nerve targets, the neurogenic bladder treatment data is synchronously collected and analyzed to obtain an evaluation value of the signal quality of the neurogenic bladder treatment and an evaluation value of the signal synchronization of the neurogenic bladder treatment, and through comprehensive analysis and optimization adjustment, the accuracy of the wearable application of the electrical stimulation treatment for neurogenic bladder is improved.

[0037] To better understand the above technical solution, the above technical solution will be described in detail below in conjunction with the accompanying drawings of the specification and specific embodiments.

[0038] As Figure 1 shown, it is a schematic structural diagram of the wearable device for tactile electrical stimulation for neurogenic bladder treatment provided by the embodiments of the present application. The wearable device for tactile electrical stimulation for neurogenic bladder treatment provided by the embodiments of the present application includes the following steps: a stimulator unit, a nerve electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is required and the stimulation parameters. The stimulation strategy unit formulates a stimulation plan according to the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electrical pulses according to the received stimulation plan and sends the electrical pulses to the nerve electrode unit through wires or wirelessly. The nerve electrode unit transmits the electrical pulses to the patient's nervous system to complete the stimulation process. Among them, the stimulator unit is the part that provides synchronous output and asynchronous output of multi-channel stimulation pulses. The multiple electrical pulses output by the stimulator are independently controllable from each other, and the amplitude parameter, pulse width parameter, and stimulation frequency parameter of the multi-channel electrical pulses are independently adjustable.

[0039] In this embodiment, the nerve electrode unit is a body surface electrode array including multiple contact electrodes with different electrode spacing distributions. The electrodes are not connected to the stimulator unit by leads. The electrode unit includes a thoracic electrode unit acting on the thoracic vertebrae T11-T12, with a thoracic electrode spacing of h1, a lumbar electrode unit acting on the lumbar vertebrae L1-L5, with a lumbar electrode spacing of h2, a sacral electrode unit acting on the sacrum S1-S5, with a sacral electrode spacing of h3, and a transverse iliac crest electrode unit acting on the iliac crest. Among them, nerve stimulation signals are generated between the corresponding selected electrodes. During motion capture, the electrodes from T11 to S5 are quickly scanned. The scanning strategy is to use the T11 electrode, L2 electrode, L5 electrode, and S3 electrode as the first-layer electrode sites, and judge the plantar movement characteristics triggered after the above sites receive the stimulation signal, marked by plantar flexion response; then use the T12, L1, L3, L4, S1, S2, S4, and S5 electrodes as the second-layer electrode sites, and judge the plantar movement characteristics triggered after the above sites receive the stimulation signal, marked by plantar flexion response, such as Figure 4 , Figure 10 and Figure 11 shown. T11-T12 is the thoracic region; h1 is the thoracic intervertebral space; L1-L5 is the lumbar region; h2 is the lumbar intervertebral space; S1-S5 is the sacral region; h3 is the sacral intervertebral space; Q1 is the iliac crest; Q2 is the iliac crest. The nerve electrode unit is an electrode array including multiple contact electrodes with different electrode spacing distributions, used to transmit multiple electrical pulses output by the stimulator unit to a specific area of the human body. The electrodes are in contact with the human skin, and the electrodes are not connected to the stimulator unit by leads. The electrode unit includes a thoracic electrode unit acting on the thoracic vertebrae T11-T12, with a thoracic electrode spacing of h1, a lumbar electrode unit acting on the lumbar vertebrae L1-L5, with a lumbar electrode spacing of h2, a sacral electrode unit acting on the sacrum S1-S5, with a sacral electrode spacing of h3, and a transverse iliac crest electrode unit acting on the iliac crest. During application, touch the position of the iliac wing with your hand, and it is easy to see the projection of the highest point of the iliac crest on the body surface. After selecting the iliac crest position, align the iliac crest electrode of the nerve electrode unit horizontally with the iliac wing, and attach the remaining electrodes along the direction of the spinal column. The electrodes of the spinal cord and lumbosacral segments and the electrodes on the iliac side are integrated for easy nerve positioning. The multi-site electrode coverage design can avoid re-tearing and re-attaching due to displacement deviation of electrode attachment; such as Figure 5 , Figure 6 and Figure 7As shown, the motion capture unit includes a motion acquisition unit distributed at the big toe of the sole and a motion acquisition unit distributed at the positions of the sole and the dorsum of the foot, which is used to collect and capture the plantar motion response after nerve stimulation. The captured signals include the flexion and extension movements of the big toe, the plantar flexion and eversion movements of the dorsum of the foot and the sole. These movements adopt a parallel capture method. The information elements include the action generation time, the instantaneous acceleration of the action, the rotation angle, etc. These information are transmitted to the signal decoding unit wirelessly, avoiding the inconvenience brought by the physical leads between the waist and the foot; the plantar motion is a reflex motion, and the trigger source is an external nerve stimulation signal worn outside the body. The nerve stimulation signal is generated between the corresponding selected electrodes. During the motion capture, the electrodes of T11-S5 will be quickly scanned. The scanning strategy is to use the T11 electrode, L2 electrode, L5 electrode, and S3 electrode as the first-layer electrode sites to judge the plantar motion characteristics triggered after the above sites receive the stimulation signal, marked by the plantar flexion response; then use the T12, L1, L3, L4, S1, S2, S4, and S5 electrodes as the second-layer electrode sites to judge the plantar motion characteristics triggered after the above sites receive the stimulation signal, marked by the plantar flexion response; the electrode gating time during the electrode site scanning is recorded as t0, the pulse at the T11 electrode is used as the starting pulse of the stimulation pulse, recorded as t1, the stimulation pulse width is t2 - t1, and the pulse end time at the S5 electrode is t13; after the action of the stimulation signal, the plantar reflex motion is triggered, and the reflex motion cycle is from hundreds of milliseconds to several seconds; the wireless transmission is an asynchronous transmission method. The wireless transmission is specifically divided into event frames and data frames. The captured signal volume is marked as different event types. The event frames are triggered by the event types, and the event frames trigger the data frames. The event frame interval is from several milliseconds to dozens of milliseconds. The data frame adopts a short frame data structure, and the data frame interval is about 1 millisecond, which can transmit all the information of the motion capture unit without omission. The purpose here is: when different nerve ganglia of T11-S5 are stimulated to cause biomarker phenomena, the motion characteristics of the human foot, etc. are a kind of biomarker, and these actions are identified by using a non-invasive method attached to the body surface to obtain the required signals. The traditional method for evaluating nerve function characteristics uses more evoked potentials, which require monitoring the nerve potential at the distal end after stimulation to respond. In order to reduce signal interference, acupuncture electrodes are often used to pierce into the subcutaneous for monitoring, which is inconvenient and the equipment is not portable; such as Figure 8 and Figure 9 shown , and is the maximum phase angle of the signal at the 1 / 4 cycle, which can be equivalently understood as the signal phase slope and is used to eliminate false signals. Ref1, Ref2, and Ref3 are three preset comparison thresholds used to eliminate false signals and are used in combination with the phase slope. For example, if the amplitude of some false signals meets the requirements but the phase slope does not, they can be quickly eliminated. The signal decoding unit performs decoding analysis based on the information collected by the motion capture unit. The wireless transmission link has marked the type of the collected signal. The 1 / 4 cycle integration method is used to calculate the signal energy value in the [0 - 1 / 4] cycle. The fast slope discriminant calculates the discrete point slope difference at the discrete points in the [0 - 1 / 4] cycle. By comparing the energy value and the slope change, the false plantar motion signals can be quickly eliminated. Subsequently, the numerical calculations of the action generation time, action instantaneous acceleration, and action rotation angle are performed. The collected values can be understood as these discrete points x1, x2..xn. Combining with the discrete point slope difference calculation mentioned by comparing the energy value and the slope change, the slope difference value is obtained. Then, based on the slope difference reflecting the action characteristics, it is judged whether the relative part of the plantar action is the big toe or the sole of the foot or the ankle joint, which can realize the fast, efficient, and high-accuracy discrimination of the motion characteristics and break through the analysis method that requires obtaining a complete cycle signal in the conventional analysis scheme. The signal decoding link performs decoding calculations in the order of the positions and time sequences of the first-layer electrode sites and the second-layer electrode sites. If the analyzed information elements are incomplete after eliminating false signals, according to the positions and time marks of the first-layer electrode sites and the second-layer electrode sites, the stimulator will send an additional frame of nerve stimulation signal to the electrode site corresponding to the false signal, so that the motion capture unit re-performs motion capture, and the captured information elements are only the types missing after elimination. After completing the data acquisition, signal decoding is performed again until the information elements are completely decoded.

[0040] such as Figure 2As shown in the figure, it is a schematic flowchart of the electrostimulation tactile evaluation method for neurogenic bladder treatment provided by the embodiments of the present application. The electrostimulation tactile evaluation method for neurogenic bladder treatment provided by the embodiments of the present application includes: collecting and processing neurogenic bladder treatment data through the nerve electrode unit and the motion capture unit in the electrostimulation tactile wearable device for neurogenic bladder treatment; analyzing the neurogenic bladder treatment data through the signal decoding unit in the electrostimulation tactile wearable device for neurogenic bladder treatment to obtain the neurogenic bladder treatment signal quality evaluation value and the neurogenic bladder treatment signal synchronization evaluation value; comprehensively analyzing through the signal decoding unit in the electrostimulation tactile wearable device for neurogenic bladder treatment to obtain the neurogenic bladder treatment signal accuracy evaluation value; comparing and analyzing the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the electrostimulation tactile wearable device for neurogenic bladder treatment to optimize and adjust the neurogenic bladder treatment signal quality method; comparing and analyzing the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value to optimize and adjust the neurogenic bladder treatment signal synchronization method; comparing and analyzing the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value to optimize and adjust the neurogenic bladder treatment signal accuracy method.

[0041] In this embodiment, the implementation process is as follows: The stimulator unit provides multi-channel stimulation pulse synchronous output and asynchronous output. The number of stimulation channels can reach 16 channels, and the multiple electrical pulses output by the stimulator are independently controllable. The stimulation pulses act on a specific electrode array in the nerve electrode unit to transmit the multiple electrical pulses output by the stimulator unit to a specific area of the human body. The electrodes are in contact with the human skin, and there is no lead connection between the electrodes and the stimulator unit. During application, touch the position of the iliac wing with your hand, and it is easy to see the projection of the highest point of the iliac crest on the body surface. After selecting the iliac crest position, align the iliac crest electrode of the nerve electrode unit with the iliac wing horizontally, and attach the remaining electrodes along the direction of the spinal column; after the stimulation pulses are output at specific positions, the motion capture unit includes a motion acquisition unit distributed at the big toe of the sole and a motion acquisition unit distributed at the positions of the sole and the instep of the foot. They are attached to the skin surface, non-invasive, and are used to collect and capture the plantar motion response after nerve stimulation. The captured signals include the flexion and extension movements of the big toe, the plantar flexion and eversion movements of the instep and the sole of the foot. The information elements include the action generation time, the instantaneous acceleration of the action, the rotation angle, the motion amplitude, the signal frequency characteristics, the signal transmission delay, the signal drift rate, the maximum phase of the signal, the minimum phase of the signal, and the time stamp, etc. These information highly corresponds to the nerve electrode site and the stimulation parameters. The information is decoded and analyzed by the signal decoding unit. The analysis method uses the 1 / 4 cycle integration method and the fast slope discrimination to quickly eliminate the pseudo-plantar motion signals, and can realize the fast, efficient, and high-accuracy discrimination of the motion characteristics, breaking through the analysis method that requires obtaining a complete cycle signal in the conventional analysis scheme; the final analysis result will be fed back to the stimulation strategy unit, which makes a strategy optimization for the adaptive adjustment of the stimulation parameters and the stimulation electrode position based on the output of the stimulator unit, so that the user is in the optimal stimulation output and clinical benefit state.

[0042] Further, the specific steps for collecting and processing the neurogenic bladder treatment data are as follows: Collect the original neurogenic bladder treatment data through the neurogenic bladder treatment electrical stimulation tactile wearable device in contact with the sole, toes, sole of the foot, instep, etc.; Clean and denoise the original neurogenic bladder treatment data to obtain the neurogenic bladder treatment data, and the neurogenic bladder treatment data includes the neurogenic bladder treatment signal quality data and the neurogenic bladder treatment signal synchronization data.

[0043] In this embodiment, place the neurogenic bladder treatment electrical stimulation tactile wearable device on parts such as the sole of the foot, and wirelessly transmit the collected motion characteristics to the wearable device for neurogenic bladder treatment for decoding and analysis.

[0044] Further, the specific steps to obtain the evaluation value of the neurogenic bladder treatment signal quality are as follows: obtaining the movement amplitude and angle characteristics of the preset neurogenic bladder treatment signal quality time detection points through the sensing devices at the soles, toes, insteps, and dorsum of the feet; obtaining the signal frequency characteristics of the preset neurogenic bladder treatment signal quality time detection points through the signal decoding unit; obtaining the stimulation frequency of the preset neurogenic bladder treatment signal quality time detection points through the nerve stimulator signal decoding unit; obtaining the amplitude value of the signal waveform center point of the preset neurogenic bladder treatment signal quality time detection points through the signal decoding unit; obtaining the time stamp of the preset neurogenic bladder treatment signal quality time detection points through the signal decoding unit; the neurogenic bladder treatment signal quality data includes movement amplitude, signal frequency characteristics, stimulation frequency, signal waveform center point amplitude value, and time stamp; analyzing the neurogenic bladder treatment signal quality data to obtain the evaluation value of the neurogenic bladder treatment signal quality.

[0045] In this embodiment, the specific method for analyzing and obtaining the evaluation value of the neurogenic bladder treatment signal quality is as follows:

[0046] ;

[0047] ; ;

[0048] ; ;

[0049] ;

[0050] Number the preset neurogenic bladder treatment signal quality time detection points in sequence, denote the th number of the neurogenic bladder treatment signal quality time detection points under the th neurogenic bladder treatment signal quality time detection segment, denote the total number of the neurogenic bladder treatment signal quality time detection points.

[0051] Divide the preset neurogenic bladder treatment signal quality time into neurogenic bladder treatment signal quality detection segments of the same time length, denote the number of the neurogenic bladder treatment signal quality detection segment, , denote the total number of the neurogenic bladder treatment signal quality detection segments.

[0052] denote the evaluation value of the neurogenic bladder treatment signal quality of the th neurogenic bladder treatment signal quality time detection point.

[0053] Indicates the motion artifact influence coefficient at the th neurogenic bladder treatment signal quality time detection point.

[0054] Indicates the th signal frequency characteristic influence coefficient at the neurogenic bladder treatment signal quality time detection point.

[0055] Indicates the th stimulation frequency at the neurogenic bladder treatment signal quality time detection point. The stimulation frequency refers to the rate at which the current / voltage is turned on and off a specific number of times per second during the electrostimulation treatment of neurogenic bladder. For example, a stimulation frequency of 20 Hz means there are 20 current / voltage pulses per second.

[0056] Indicates the standard value of the stimulation frequency, which is a preset stimulation frequency standard value obtained from the neurogenic bladder treatment database and can be the average value of the stimulation frequencies preset at the neurogenic bladder treatment signal quality time detection points in the historical database.

[0057] Indicates the th signal fluctuation coefficient in the neurogenic bladder treatment signal quality time detection segment.

[0058] Indicates the th timestamp at the neurogenic bladder treatment signal quality time detection point.

[0059] Indicates the standard value of the timestamp, which is a preset timestamp standard value obtained from the neurogenic bladder treatment database and can be the average value of the timestamps preset at the neurogenic bladder treatment signal quality time detection points in the historical database.

[0060] Indicates the th amplitude value of the signal waveform center point in the neurogenic bladder treatment signal quality time detection segment.

[0061] Indicates the standard value of the amplitude value of the signal waveform center point, which is a preset standard value of the amplitude value of the signal waveform center point obtained from the neurogenic bladder treatment database and can be the average value of the amplitude values of the signal waveform center points preset at the neurogenic bladder treatment signal quality time detection segments in the historical database.

[0062] Denotes the standard value of signal waveform deviation, which is a preset signal waveform deviation standard value obtained from the neurogenic bladder treatment database and can be the average value of signal waveform deviations under the preset neurogenic bladder treatment signal quality time detection segment in the historical database.

[0063] Denotes the movement amplitude at the

[0064] Denotes the standard value of movement amplitude, which is a preset movement amplitude standard value obtained from the neurogenic bladder treatment database and can be the average value of movement amplitudes under the preset neurogenic bladder treatment signal quality time detection segment in the historical database.

[0065] Denotes the signal frequency characteristics at the

[0066] Denotes the standard value of signal frequency characteristics, which is a preset signal frequency characteristics standard value obtained from the neurogenic bladder treatment database and can be the average value of signal frequency characteristics under the preset neurogenic bladder treatment signal quality time detection point in the historical database.

[0067] Is the preset stimulation frequency weight influence factor obtained from the neurogenic bladder treatment database.

[0068] Is the preset signal fluctuation coefficient weight influence factor obtained from the neurogenic bladder treatment database.

[0069] Is the preset timestamp weight influence factor obtained from the neurogenic bladder treatment database.

[0070] Is the preset movement artifact influence factor obtained from the neurogenic bladder treatment database.

[0071] Is the preset signal frequency characteristics influence factor obtained from the neurogenic bladder treatment database.

[0072] The preset stimulation frequency weight influencing factor, the preset signal fluctuation coefficient weight influencing factor, and the preset timestamp weight influencing factor are obtained through a mapping relationship. For example, mapping sets of the stimulation frequency, the signal fluctuation coefficient, and the timestamp to their corresponding weights are established respectively based on the relationships among the stimulation frequency, the signal fluctuation coefficient, and the timestamp in historical data, and the corresponding preset stimulation frequency weight influencing factor, preset signal fluctuation coefficient weight influencing factor, and preset timestamp weight influencing factor in the mapping set are obtained by inputting the real-time stimulation frequency, signal fluctuation coefficient, and timestamp.

[0073] The preset motion artifact influencing factor and the preset signal frequency characteristic influencing factor are obtained through a mapping relationship. For example, mapping sets of the motion artifact and the signal frequency characteristic to their corresponding weights are established respectively based on the relationships between the motion artifact and the signal frequency characteristic and the stimulation frequency in historical data, and the corresponding preset motion artifact influencing factor and preset signal frequency characteristic influencing factor in the mapping set are obtained by inputting the real-time motion artifact and signal frequency characteristic.

[0074] Specifically, as shown in Table 1, in the treatment of neurogenic bladder, the wearable device for treating neurogenic bladder regulates bladder function through electrical pulse stimulation. The design of its stimulation strategy unit is to optimize the stimulation effect and improve the signal quality of neurogenic bladder treatment. For example, the signal quality evaluation value of neurogenic bladder is related to the patient's response to electrical stimulation. Mn reflects the movement characteristics caused by electrical pulses. If Mn can effectively cause muscle activities that contribute to urination, the signal quality of neurogenic bladder is improved. The stimulation strategy is as follows: STRn is the stimulation pulse strategy for the nth pair. There are multiple combinations of electrode arrangements in the T11-S5 region. Selecting different combinations brings different movement behaviors. The value of Mn is assigned different factor coefficients according to the movement characteristics generated after different electrode combinations, and the value range is [0, 1]. Mn is the coefficient corresponding to the movement characteristics captured after the action of the nth pair of stimulation pulses. En is the coefficient corresponding to the nth pair of electrode regions. There are multiple combinations of electrode arrangements in the T11-S5 region. The value of En will give different proportionality coefficients according to different arrangements, which is a proportionality factor in the range of [0, 1]. An is the stimulation intensity output between the nth pair of electrodes, Fn is the output stimulation frequency between the nth pair of electrodes, and Pwn is the output stimulation pulse width between the nth pair of electrodes. The stimulation pulse width refers to the duration of a single pulse in the electrical stimulation signal. Syn is the synchronous asynchronous factor, An is the stimulation intensity between different electrodes, with a value range of [0, 100], Fn is the output frequency between different electrodes, with a value range of [0, 50K], Pwn is the pulse width between different electrodes, with a value range of [0, 1000], Syn is the stimulation synchronous asynchronous factor, which is a compensation coefficient in the algorithm, with a value range of [0, 1], Num is the number of working electrodes. Multiple pairs of electrodes between T11-S5 can output electrical pulses synchronously or asynchronously. STRn = Mn * En * An * Fn * Pwn * Syn * Num. The stimulation intensity, stimulation frequency, and stimulation pulse width between each electrode are independently adjustable. The adjustment strategy is that when the result of the signal decoding unit shows the dorsal flexion response characteristic at the ankle joint, it indicates that the electrode stimulation area is at the lumbar vertebra, and the priority control electrodes are L4-L5. When the decoding result shows plantar flexion of the big toe, it indicates that the electrode stimulation area is at the sacrum, and the priority control electrodes are S1-S2.

[0075] Specifically, functional weight factors are pre-assigned for the movement part and movement characteristics 、 、 、 、 、 First, use the T11, L2, L5, and S3 electrodes as the first-layer electrode sites. These electrodes are approximately equally spaced in the T11-S5 electrode span and can perform a rapid preliminary screening of the effective electrode area. The plantar movement characteristics triggered after the above sites receive the stimulation signal are recorded as M1.

[0076] , in the M1 matrix, An_m is the motion characteristic coefficient caused by the operation of the nth electrode and the mth electrode, and this coefficient is related to the functional weight factor λ, that is , the M1 matrix is normalized and transformed row by row and column to obtain the M1' matrix, and the eigenvector corresponding to the M1' matrix is calculated , , the maximum value of the eigenvector is the priority working electrode site.

[0077] Then, using the T12, L1, L3, L4, S1, S2, S4, S5 electrodes as the second-layer electrode sites, the motion characteristic is denoted as M2, which is used for fine selection of electrode positions in the effective electrode region preliminarily screened by the M1 matrix.

[0078] , in the M2 matrix, An_m is the motion characteristic coefficient caused by the operation of the nth electrode and the mth electrode, and this coefficient is related to the functional weight factor related, that is , the M2 matrix is normalized and transformed row by row and column to obtain the M2' matrix, and the eigenvector corresponding to the M2' matrix is calculated , the maximum value of the eigenvector is the priority working electrode site.

[0079] Substitute the discrete An_m in the M1' and M2' matrices into the matrix according to the electrode distribution positions to form the M' matrix. The M' matrix is the matrix of the corresponding coefficients of the motion characteristics captured between the T11 - S5 electrode arrays.

[0080] , in the M' matrix, Mn_m is the motion characteristic coefficient between the nth electrode and the mth electrode, and calculate the product value of each row in the M' matrix , generate the En coefficient according to the product result, and generate the An, Fn, and Pwn coefficient values by the weight factors and , , and finally the regulation strategy transmitted to the stimulator is STRn = M' * En * An * Fn * Pwn * Syn * Num.

[0081]

[0082] Table 1 Regulation Strategy Table for Neurogenic Bladder Treatment

[0083] The higher the motion amplitude, the greater the action potential caused by nerve innervation and the greater the signal characteristic; the stimulation frequency refers to the frequency of the stimulation signal externally applied to the neuromuscular junction, and the stimulation frequency is related to the dynamic range of the activity of the innervated neuromuscular; the change in the signal frequency characteristic reflects the stability of the amplitude of the center point of the signal waveform; the time stamp is related to the dynamic range of the motion amplitude and reflects the motion amplitude characteristic.

[0084] There is a positive correlation between the square of the difference between the movement amplitude and the standard value of the movement amplitude and the evaluation value of the signal quality of neurogenic bladder treatment. The larger the square of the difference between the movement amplitude and the standard value of the movement amplitude, the larger the evaluation value of the signal quality of neurogenic bladder treatment; there is a positive correlation between the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics and the evaluation value of the signal quality of neurogenic bladder treatment. The larger the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics, the larger the evaluation value of the signal quality of neurogenic bladder treatment; there is a positive correlation between the absolute value of the difference between the stimulation frequency and the standard value of the stimulation frequency and the evaluation value of the signal quality of neurogenic bladder treatment. If the stimulation frequency does not match the foot-end movement characteristics, the worse the signal quality of neurogenic bladder treatment. The larger the absolute value of the difference between the stimulation frequency and the standard value of the stimulation frequency, the larger the evaluation value of the signal quality of neurogenic bladder treatment; there is a positive correlation between the square of the difference between the amplitude value of the signal waveform center point and the amplitude value of the signal waveform center point and the evaluation value of the signal quality of neurogenic bladder treatment. If there is obvious drift or deviation of the signal, the larger the square of the difference between the amplitude value of the signal waveform center point and the amplitude value of the signal waveform center point, the larger the evaluation value of the signal quality of neurogenic bladder treatment; there is a positive correlation between the absolute value of the difference between the time stamp and the standard value of the time stamp and the evaluation value of the signal quality of neurogenic bladder treatment.

[0085] Further, the specific process for obtaining the evaluation value of the synchronization of neurogenic bladder treatment signals is as follows: obtaining the movement amplitude and angle characteristics of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the sensing devices at the sole, toes, instep, and dorsal surface of the foot; obtaining the signal frequency characteristics of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; obtaining the signal transmission delay of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; obtaining the signal drift rate of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; obtaining the signal maximum phase of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; obtaining the signal minimum phase of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; obtaining the time stamp of the preset time detection points of the synchronization of neurogenic bladder treatment signals through the signal decoding unit; the synchronization data of the neurogenic bladder treatment signals includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase, and time stamp; analyzing the synchronization data of the neurogenic bladder treatment signals to obtain the evaluation value of the synchronization of neurogenic bladder treatment signals.

[0086] In this embodiment, the specific method for analyzing and obtaining the evaluation value of the synchronization of neurogenic bladder treatment signals is as follows:

[0087] ;

[0088] ; ;

[0089] ; ;

[0090] ;

[0091] Number the preset neurogenic bladder treatment signal synchronization time detection points in sequence, indicating the number of the neurogenic bladder treatment signal synchronization time detection point under the th neurogenic bladder treatment signal synchronization time detection segment, , indicating the total number of the neurogenic bladder treatment signal synchronization time detection point numbers.

[0092] Divide the preset neurogenic bladder treatment signal synchronization time into neurogenic bladder treatment signal synchronization detection segments of the same time length, indicating the number of the neurogenic bladder treatment signal synchronization detection segment, , indicating the total number of the neurogenic bladder treatment signal synchronization detection segment numbers.

[0093] indicating the neurogenic bladder treatment signal synchronization evaluation value of the th neurogenic bladder treatment signal synchronization time detection point.

[0094] indicating the motion artifact correction coefficient under the th neurogenic bladder treatment signal synchronization time detection point.

[0095] indicating the signal frequency characteristic correction coefficient under the th neurogenic bladder treatment signal synchronization time detection point.

[0096] indicating the signal transmission delay threshold, which is a preset signal transmission delay threshold obtained from the neurogenic bladder treatment database and can be the average value of the signal transmission delays under the preset neurogenic bladder treatment signal synchronization time detection points in the historical database.

[0097] indicating the transmission delay under the th neurogenic bladder treatment signal synchronization time detection point.

[0098] Denotes the standard value of signal drift deviation, which is a preset signal drift deviation standard value obtained from the neurogenic bladder treatment database and can be the average value of signal drift deviations at the preset neurogenic bladder treatment signal synchronization time detection points in the historical database.

[0099] Denotes the signal drift rate at the

[0100] th neurogenic bladder treatment signal synchronization time detection point. During the treatment of neurogenic bladder, the signal drift rate refers to the unexpected and slow change of the signal baseline over time during signal acquisition due to reasons of the instrument or the organism.

[0101] Denotes the signal phase synchronization coefficient at the

[0102] th neurogenic bladder treatment signal synchronization time detection segment.

[0103] Denotes the time stamp at the

[0104] th neurogenic bladder treatment signal synchronization time detection point. Denotes the movement amplitude at the

[0105] th neurogenic bladder treatment signal synchronization time detection point.

[0106] Denotes the signal frequency feature at the

[0107] Represents the standard value of the signal frequency feature, which is a preset signal frequency feature standard value obtained from the neurogenic bladder treatment database and can be the average value of the signal frequency features at the preset neurogenic bladder treatment signal synchronization time detection points in the historical database.

[0108] Represents the maximum phase of the signal in the

[0109] Represents the minimum phase of the signal in the

[0110] Represents the standard value of the signal phase deviation, which is a preset signal phase deviation standard value obtained from the neurogenic bladder treatment database and can be the average value of the signal phase deviations at the preset neurogenic bladder treatment signal synchronization time detection segments in the historical database.

[0111] Is the preset signal transmission delay weight influence factor obtained from the neurogenic bladder treatment database.

[0112] Is the preset signal drift rate weight influence factor obtained from the neurogenic bladder treatment database.

[0113] Is the preset signal phase synchronization coefficient weight influence factor obtained from the neurogenic bladder treatment database.

[0114] Is the preset timestamp weight influence factor obtained from the neurogenic bladder treatment database.

[0115] Is the preset motion artifact correction factor obtained from the neurogenic bladder treatment database.

[0116] Is the preset signal frequency feature correction factor obtained from the neurogenic bladder treatment database.

[0117] The preset signal transmission delay weight impact factor, preset signal drift rate weight impact factor, preset signal phase synchronization coefficient weight impact factor, and preset timestamp weight impact factor are obtained through a mapping relationship. For example, mapping sets of the signal transmission delay, signal drift rate, signal phase synchronization coefficient, and timestamp to their corresponding weights are established respectively based on the relationships between the signal transmission delay, signal drift rate, signal phase synchronization coefficient, and timestamp and the signal amplitude in historical data. The corresponding preset signal transmission delay weight impact factor, preset signal drift rate weight impact factor, preset signal phase synchronization coefficient weight impact factor, and preset timestamp weight impact factor in the mapping set are obtained by inputting the real-time signal transmission delay, signal drift rate, signal phase synchronization coefficient, and timestamp.

[0118] The preset motion artifact correction factor and preset signal frequency characteristic correction factor are obtained through a mapping relationship. For example, mapping sets of the motion artifact and signal frequency characteristic to their corresponding weights are established respectively based on the relationships between the motion artifact and signal frequency characteristic and the signal drift rate in historical data. The corresponding preset motion artifact correction factor and preset signal frequency characteristic correction factor in the mapping set are obtained by inputting the real-time motion artifact and signal frequency characteristic.

[0119] Specifically, in the treatment of neurogenic bladder, the synchronization evaluation value of the neurogenic bladder treatment signal involves the synchronization of the stimulation signal, that is, whether the electrical pulses of different channels can be accurately output according to the preset synchronization strategy, which is directly related to the function of the stimulator unit. Synchronous output means that the electrical pulses of all channels are emitted at the same moment or in a specific order simultaneously.

[0120] The greater the motion amplitude, the greater the action potential caused by nerve innervation and the greater the signal characteristics. The signal transmission delay refers to the time difference between the generation of the signal and its recording by the detection system. The timestamp provides the time information of the signal occurrence. The larger the timestamp, the greater the signal transmission delay. The signal drift rate refers to the rate of change of the signal baseline over time and affects the motion amplitude. The greater the signal drift rate, the greater the impact on the motion amplitude. The signal maximum phase and signal minimum phase provide information about the change of the signal waveform over time.

[0121] There is a negative correlation between the square of the difference between the movement amplitude and the standard value of the movement amplitude and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the movement amplitude and the standard value of the movement amplitude, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the signal transmission delay and the synchronization evaluation value of the neurogenic bladder treatment signal, resulting in a mismatch between the treatment signal and the foot-end movement characteristics. The larger the signal transmission delay, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the absolute value of the difference between the signal drift rate and the standard value of the signal drift rate and the synchronization evaluation value of the neurogenic bladder treatment signal, indicating that the signal baseline is unstable and affects the signal synchronization. The larger the absolute value of the difference between the signal drift rate and the standard value of the signal drift rate, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the square of the difference between the maximum phase and the minimum phase of the signal and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the maximum phase and the minimum phase of the signal, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the absolute value of the difference between the time stamp and the standard value of the time stamp and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the absolute value of the difference between the time stamp and the standard value of the time stamp, the more it affects the signal synchronization, and the smaller the synchronization evaluation value of the neurogenic bladder treatment signal.

[0122] Further, the specific steps for comprehensively analyzing and obtaining the accuracy evaluation value of the neurogenic bladder treatment signal are as follows: obtaining the signal transmission rate at the preset accuracy time detection point of the neurogenic bladder treatment signal through the signal decoding unit; comprehensively analyzing the synchronization evaluation value of the neurogenic bladder treatment signal, the signal transmission rate, and the quality evaluation value of the neurogenic bladder treatment signal to obtain the accuracy evaluation value of the neurogenic bladder treatment signal.

[0123] In this embodiment, the specific method for analyzing and obtaining the accuracy evaluation value of the neurogenic bladder treatment signal is as follows:

[0124] ;

[0125] ;

[0126] Number the preset accuracy time detection points of the neurogenic bladder treatment signal in sequence, indicating the number of the accuracy time detection point of the neurogenic bladder treatment signal, , indicating the total number of the accuracy time detection points of the neurogenic bladder treatment signal.

[0127] Represents the accuracy evaluation value of the neurogenic bladder treatment signal.

[0128] Represents the synchronization evaluation value of the neurogenic bladder treatment signal at the

[0129] th synchronization time detection point of the neurogenic bladder treatment signal. Represents the signal transmission rate at the

[0130] th accuracy time detection point of the neurogenic bladder treatment signal.

[0131] Represents the quality evaluation value of the neurogenic bladder treatment signal at the

[0132] th quality time detection point of the neurogenic bladder treatment signal.

[0133] Is the preset weight influence factor of the signal transmission rate obtained from the neurogenic bladder treatment database.

[0134] Is the preset weight influence factor of the quality evaluation value of the neurogenic bladder treatment signal obtained from the neurogenic bladder treatment database.

[0135] The preset weight influence factor of the synchronization evaluation value of the neurogenic bladder treatment signal, the preset weight influence factor of the signal transmission rate, and the preset weight influence factor of the quality evaluation value of the neurogenic bladder treatment signal are obtained through a mapping relationship. For example, by establishing mapping sets of the quality evaluation index of the neurogenic bladder treatment signal, the synchronization evaluation index of the neurogenic bladder treatment signal, and the signal transmission rate and its corresponding weights respectively based on the relationship between the quality evaluation index of the neurogenic bladder treatment signal, the synchronization evaluation index of the neurogenic bladder treatment signal, and the signal transmission rate and signal transmission delay in historical data, and obtaining the corresponding preset weight influence factor of the synchronization evaluation value of the neurogenic bladder treatment signal, the preset weight influence factor of the signal transmission rate, and the preset weight influence factor of the quality evaluation value of the neurogenic bladder treatment signal in the mapping set by inputting the real-time quality evaluation index of the neurogenic bladder treatment signal, the synchronization evaluation index of the neurogenic bladder treatment signal, and the signal transmission rate.

[0136] Specifically, in the treatment of neurogenic bladder, for example, the accuracy evaluation value of the neurogenic bladder treatment signal is directly related to the accuracy of the electrical pulse signal output by the stimulator unit, including whether the amplitude, width, and frequency of the electrical pulse are accurately output according to the preset parameters. If the electrical pulse output by the stimulator unit is inaccurate, the accuracy of the neurogenic bladder treatment-related signal will decrease; the electrode array of the nerve electrode unit accurately transmits the electrical pulse to a specific area of the human body, and the accuracy of the electrode spacing and position is crucial for the transmission of the neurogenic bladder signal. If the electrode position or spacing is inaccurate, it will lead to inaccurate transmission of the neurogenic bladder signal, thereby affecting the accuracy of the neurogenic bladder signal.

[0137] The synchronization evaluation value of the neurogenic bladder treatment signal is whether each channel can accurately output according to the preset synchronization strategy when the stimulator unit outputs multi-channel electrical pulses. The faster the signal transmission rate, the more likely the stimulation signal can reach the target position at the correct time, and the greater the synchronization evaluation value of the neurogenic bladder treatment signal; the signal transmission rate refers to the speed of the signal from generation to transmission and then to reception. In the treatment of neurogenic bladder, the faster the signal transmission rate, the less signal delay, and the smaller the quality evaluation value of the neurogenic bladder treatment signal; in the treatment of neurogenic bladder, the smaller the synchronization of the neurogenic bladder treatment signal, the worse the quality of the neurogenic bladder treatment signal, the greater the synchronization evaluation value of the neurogenic bladder treatment signal, and the smaller the quality evaluation value of the neurogenic bladder treatment signal.

[0138] There is a positive correlation between the synchronization evaluation value of the neurogenic bladder treatment signal and the accuracy evaluation value of the neurogenic bladder treatment signal. The higher the synchronization of the neurogenic bladder treatment signal, it means that the stimulation signal can accurately and synchronously reach the target nerve at the predetermined time, the greater the synchronization evaluation value of the neurogenic bladder treatment signal, and the greater the accuracy evaluation value of the neurogenic bladder treatment signal; there is a positive correlation between the signal transmission rate and the accuracy evaluation value of the neurogenic bladder treatment signal. Reducing the delay of the signal during transmission and ensuring that the stimulation signal reaches the target position in time, the faster the signal transmission rate, the greater the accuracy evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the quality evaluation value of the neurogenic bladder treatment signal and the accuracy evaluation value of the neurogenic bladder treatment signal. The worse the quality of the neurogenic bladder treatment signal, the more it affects the synchronization of the neurogenic bladder treatment signal, the greater the quality evaluation value of the neurogenic bladder treatment signal, and the smaller the accuracy evaluation value of the neurogenic bladder treatment signal.

[0139] Further, the specific steps for optimizing the quality of neurogenic bladder treatment signals are as follows: If the evaluation value of the quality of neurogenic bladder treatment signals is lower than or equal to the first threshold of the evaluation value of the quality of neurogenic bladder treatment signals, there is no need to optimize the method for the quality of neurogenic bladder treatment signals; if the evaluation value of the quality of neurogenic bladder treatment signals is higher than the first threshold of the evaluation value of the quality of neurogenic bladder treatment signals, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the evaluation value of the quality of neurogenic bladder treatment signals and the first threshold of the evaluation value of the quality of neurogenic bladder treatment signals.

[0140] In this embodiment, assume that the evaluation value of the quality of neurogenic bladder treatment signals is 5, the first threshold of the evaluation value of the quality of neurogenic bladder treatment signals obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is 2. Then, the adjustment plan corresponding to the difference of 2 between the evaluation value of the quality of neurogenic bladder treatment signals and the first threshold of the evaluation value of the quality of neurogenic bladder treatment signals is matched from the neurogenic bladder treatment database. The adjustment plan is: adjust the gating site of the stimulator electrode and adjust the stimulation output intensity to reduce the evaluation value of the quality of neurogenic bladder treatment signals.

[0141] Further, the specific steps for optimizing the synchronization of neurogenic bladder treatment signals are as follows: If the evaluation value of the synchronization of neurogenic bladder treatment signals is greater than or equal to the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals, there is no need to optimize the method for the synchronization of neurogenic bladder treatment signals; if the evaluation value of the synchronization of neurogenic bladder treatment signals is lower than the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the evaluation value of the synchronization of neurogenic bladder treatment signals and the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals.

[0142] In this embodiment, assume that the evaluation value of the synchronization of neurogenic bladder treatment signals is 2, the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is -1. Then, the adjustment plan corresponding to the difference of -1 between the evaluation value of the synchronization of neurogenic bladder treatment signals and the second threshold of the evaluation value of the synchronization of neurogenic bladder treatment signals is matched from the neurogenic bladder treatment database. The adjustment plan is: adjust the stimulation output frequency and adjust the sampling interval to increase the evaluation value of the synchronization of neurogenic bladder treatment signals.

[0143] Further, the specific steps for optimizing the accuracy of the neurogenic bladder treatment signal are as follows: Extract the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value from the neurogenic bladder treatment database, and compare the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value; If the neurogenic bladder treatment signal accuracy evaluation value is greater than or equal to the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, there is no need to optimize the method for the accuracy of the neurogenic bladder treatment signal; If the neurogenic bladder treatment signal accuracy evaluation value is lower than the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal accuracy evaluation value and the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value.

[0144] In this embodiment, assume that the neurogenic bladder treatment signal accuracy evaluation value is 1, the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is -2. Then, the adjustment plan corresponding to the difference of -2 between the neurogenic bladder treatment signal accuracy evaluation value and the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value is matched from the neurogenic bladder treatment database. The adjustment plan is: Adjust the sampling rate and sampling interval to improve the neurogenic bladder treatment signal accuracy evaluation value.

[0145] Such as Figure 3As shown in the figure, it is a schematic structural diagram of the electrostimulation tactile evaluation system for neurogenic bladder treatment provided by the embodiments of the present application. The electrostimulation tactile evaluation system for neurogenic bladder treatment provided by the embodiments of the present application includes: a module for collecting neurogenic bladder treatment data, a module for analyzing neurogenic bladder treatment data, a comprehensive analysis module, and an optimization and adjustment module. The module for collecting neurogenic bladder treatment data is used to collect and process neurogenic bladder treatment data through the nerve electrode unit and the motion capture unit in the electrostimulation tactile wearable device for neurogenic bladder treatment. The module for analyzing neurogenic bladder treatment data is used to analyze the neurogenic bladder treatment data through the signal decoding unit in the electrostimulation tactile wearable device for neurogenic bladder treatment to obtain the neurogenic bladder treatment signal quality evaluation value and the neurogenic bladder treatment signal synchronization evaluation value. The comprehensive analysis module is used to comprehensively analyze through the signal decoding unit in the electrostimulation tactile wearable device for neurogenic bladder treatment to obtain the neurogenic bladder treatment signal accuracy evaluation value. The optimization and adjustment module is used to compare and analyze the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the electrostimulation tactile wearable device for neurogenic bladder treatment, and optimize and adjust the method for the neurogenic bladder treatment signal quality; compare and analyze the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value, and optimize and adjust the method for the neurogenic bladder treatment signal synchronization; compare and analyze the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, and optimize and adjust the method for the neurogenic bladder treatment signal accuracy.

[0146] Those skilled in the art should understand that the embodiments of the present invention can be provided as a method, a system, or a computer program product. Therefore, the present invention can take the form of an entirely hardware embodiment, an entirely software embodiment, or an embodiment combining software and hardware aspects. Moreover, the present invention can take the form of a computer program product implemented on one or more computer-usable storage media (including but not limited to disk storage, CD-ROM, optical storage, etc.) containing computer-usable program code.

[0147] The present invention is described with reference to the flowcharts and / or block diagrams of systems, devices (systems), and computer program products according to the embodiments of the present invention. It should be understood that each process and / or block in the flowchart and / or block diagram, and the combination of processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to the processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to generate a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate for implementing in the process Figure 1 one process or multiple processes and / or blocksFigure 1 a device for the functions specified in one or more boxes

[0148] These computer program instructions can also be stored in a computer-readable memory that can direct a computer or other programmable data processing device to work in a specific manner, so that the instructions stored in the computer-readable memory produce a manufactured article including an instruction device, and the instruction device implements the process Figure 1 one process or more processes and / or boxes Figure 1 the functions specified in one or more boxes

[0149] These computer program instructions can also be loaded onto a computer or other programmable data processing device, so that a series of operation steps are executed on the computer or other programmable device to produce a computer-implemented process. Thus, the instructions executed on the computer or other programmable device provide steps for implementing the functions specified in Figure 1 one process or more processes and / or boxes Figure 1 the functions specified in one or more boxes

[0150] Although the preferred embodiments of the present invention have been described, those skilled in the art can make additional changes and modifications once they learn the basic creative concept. Therefore, the appended claims are intended to be construed to include the preferred embodiments and all changes and modifications falling within the scope of the present invention

[0151] Obviously, those skilled in the art can make various changes and deformations to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and deformations of the present invention fall within the scope of the claims of the present invention and their equivalent technologies, the present invention also intends to include these modifications and deformations

Claims

1. A tactile evaluation system for electrical stimulation of neurogenic bladder treatment, characterized in that: include: Neurogenic bladder treatment data collection module, neurogenic bladder treatment data analysis module, comprehensive analysis module and optimization adjustment module: The module for collecting neurogenic bladder treatment data is used to collect and process neurogenic bladder treatment data through the neural electrode unit and the motion capture unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; The neurogenic bladder treatment data analysis module is used to analyze the neurogenic bladder treatment data through the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain the neurogenic bladder treatment signal quality evaluation value and the neurogenic bladder treatment signal synchronization evaluation value; The comprehensive analysis module is used to obtain the accuracy evaluation value of the neurogenic bladder treatment signal through comprehensive analysis of the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; The optimization and adjustment module is used to compare and analyze the neurogenic bladder treatment signal quality assessment value with the first threshold of the neurogenic bladder treatment signal quality assessment value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize and adjust the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization assessment value with the second threshold of the neurogenic bladder treatment signal synchronization assessment value, and optimize and adjust the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, and optimize and adjust the neurogenic bladder treatment signal accuracy method.

2. The electrical stimulation tactile evaluation system for neurogenic bladder treatment as claimed in claim 1, characterized in that: The electrical stimulation tactile wearable device for treating neurogenic bladder includes: a stimulator unit, a neural electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is needed and the parameters of the stimulation. The stimulation strategy unit formulates a stimulation plan according to the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electric pulses according to the received stimulation plan, and sends the electric pulses to the neural electrode unit through a wire or wirelessly. The neural electrode unit covers the thoracic vertebrae, lumbar vertebrae, sacrum and iliac wing, and transmits the electric pulses to the patient's nervous system to complete the stimulation process. The stimulator unit is a part that provides synchronous and asynchronous output of multi-channel stimulation pulses. The multi-channel electric pulses output by the stimulator are independently controllable, and the amplitude parameters, pulse width parameters and stimulation frequency parameters of the multi-channel electric pulses are independently adjustable. During the stimulation, target screening and related motion capture are completed through the first layer of electrode sites and the second layer of electrode sites.

3. The electrical stimulation tactile evaluation system for neurogenic bladder treatment as claimed in claim 1, characterized in that: The specific steps of collecting and processing neurogenic bladder treatment data are as follows: The original data of neurogenic bladder treatment is collected by touching the soles, toes, soles and insteps of the feet with the neurogenic bladder treatment electrical stimulation tactile wearable device; The original neurogenic bladder treatment data is cleaned and denoised to obtain neurogenic bladder treatment data, wherein the neurogenic bladder treatment data includes neurogenic bladder treatment signal quality data and neurogenic bladder treatment signal synchronization data.

4. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific steps of obtaining the neurogenic bladder treatment signal quality evaluation value are as follows: The motion amplitude and angle characteristics of the preset neurogenic bladder treatment signal quality time detection point are obtained through the sensor devices at the sole, toes, sole and instep; The signal frequency characteristics of the preset neurogenic bladder treatment signal quality time detection point are obtained through the signal decoding unit; The stimulation frequency of the preset neurogenic bladder treatment signal quality time detection point is obtained by the neurostimulator; The signal waveform center point amplitude value of the preset neurogenic bladder treatment signal quality time detection point is obtained through the signal decoding unit; Obtaining a timestamp of a preset neurogenic bladder treatment signal quality time detection point through a signal decoding unit; The neurogenic bladder treatment signal quality data includes movement amplitude, signal frequency characteristics, stimulation frequency, signal waveform center point amplitude value and timestamp; The neurogenic bladder treatment signal quality assessment value is obtained based on the neurogenic bladder treatment signal quality data analysis.

5. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific process of obtaining the synchronization evaluation value of the neurogenic bladder treatment signal is as follows: The motion amplitude and angle characteristics of the preset neurogenic bladder treatment signal synchronization time detection point are obtained through the sensor devices at the sole, toes, sole and instep; The signal frequency characteristics of the preset neurogenic bladder treatment signal synchronization time detection point are obtained through the signal decoding unit; The signal transmission delay of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The signal drift rate of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The maximum phase of the signal of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The signal minimum phase of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; Obtaining the timestamp of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; The neurogenic bladder treatment signal synchronization data includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase and time stamp; The neurogenic bladder treatment signal synchronization evaluation value is obtained based on the neurogenic bladder treatment signal synchronization data analysis.

6. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific steps of comprehensively analyzing and obtaining the accuracy evaluation value of the neurogenic bladder treatment signal are as follows: The signal transmission rate of the preset neurogenic bladder treatment signal accuracy time detection point is obtained through the signal decoding unit; The accuracy assessment value of the neurogenic bladder treatment signal is obtained through comprehensive analysis of the neurogenic bladder treatment signal synchronization assessment value, signal transmission rate and neurogenic bladder treatment signal quality assessment value.

7. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific steps of the method for optimizing and adjusting the quality of neurogenic bladder treatment signals are as follows: If the neurogenic bladder treatment signal quality assessment value is lower than or equal to the neurogenic bladder treatment signal quality assessment value first threshold, there is no need to optimize and adjust the neurogenic bladder treatment signal quality method; If the neurogenic bladder treatment signal quality assessment value is higher than the first threshold value of the neurogenic bladder treatment signal quality assessment value, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal quality assessment value and the first threshold value of the neurogenic bladder treatment signal quality assessment value.

8. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific steps of the method for optimizing and adjusting the synchronization of neurogenic bladder treatment signals are as follows: If the neurogenic bladder treatment signal synchronization evaluation value is greater than or equal to the neurogenic bladder treatment signal synchronization evaluation value second threshold value, there is no need to optimize and adjust the neurogenic bladder treatment signal synchronization method; If the neurogenic bladder treatment signal synchronization evaluation value is lower than the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal synchronization evaluation value and the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value.

9. The electrical stimulation tactile evaluation system for neurogenic bladder treatment according to claim 1, characterized in that: The specific steps of the method for optimizing and adjusting the accuracy of neurogenic bladder treatment signals are as follows: Extracting a comprehensive threshold value of the neurogenic bladder treatment signal accuracy assessment value from a neurogenic bladder treatment database, and comparing the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold value of the neurogenic bladder treatment signal accuracy assessment value; If the neurogenic bladder treatment signal accuracy assessment value is greater than or equal to the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold, there is no need to optimize and adjust the neurogenic bladder treatment signal accuracy method; If the neurogenic bladder treatment signal accuracy assessment value is lower than the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal accuracy assessment value and the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold.

Images